DarshanTalks Podcast

301 Episodes

1. Responding to an FDA Inspection – Part 1 (FDA Findings, What the FDA Can Do)

   Published: 8/8/2019
2. Responding to an FDA Inspection – Part 2 (FDA Findings, What the FDA Can Do)

   Published: 8/8/2019
3. Responding to an FDA Inspection – Part 4 (Preparing a War Room)

   Published: 8/8/2019
4. Diving Deeper Into Understanding Bioethics

   Published: 8/8/2019
5. 10 Ways to Communicate With the FDA

   Published: 8/1/2019
6. FDA and Vaping: Influencer Marketing Warning

   Published: 7/23/2019
7. Types of Ethics

   Published: 7/20/2019
8. ENDS Product Marketing: FDA releases guidance on marketing vaping products

   Published: 7/16/2019
9. 23&me and Ethical Engagement

   Published: 7/11/2019
10. FDA Warning Letter: Vivus

    Published: 7/11/2019
11. Government Shutdowns & Patient Centricity

    Published: 6/6/2019
12. CBD: FDA Hearing

    Published: 5/31/2019
13. Minimizing Participant Loss in Clinical Trials – Part 2

    Published: 5/30/2019
14. Minimizing Participant Loss in Clinical Trials – Part 1

    Published: 5/23/2019
15. Why Patients Aren’t Joining Your Clinical Trial – Part 2

    Published: 5/16/2019
16. Why Patients Aren’t Joining Your Clinical Trial – Part 1

    Published: 5/8/2019
17. Patient Centricity | Gavel and Pestle

    Published: 11/29/2018
18. The Future of Amazon’s Online Pharmacy | Gavel and Pestle

    Published: 10/5/2018
19. 3 Ways For Pharmacists to Survive Amazon | Gavel and Pestle

    Published: 10/5/2018
20. Fraud and Pharmacists | Gavel and Pestle Podcast

    Published: 10/5/2018